Abhishek Garg, Research Associate Professor at KU Leuven, shared a post on LinkedIn:
“Eagerly looking forward to speaking about: ‘A multiomics spatial context in cancer: from immunobiology to next-generation therapies’ at next week’s ESMO conference, in this wonderful session on ‘Immunobiology in primary vs metastatic disease’ alongside some excellent researchers: Daniela Thommen, Niels Halama, Göran B Jönsson
Here, I will also reveal our first/best-in-class trispecific macrophage activator (TriMA) antibody capable of achieving >90% tumour inhibition against preclinical tumours refractory to all classes of immunotherapies including the latest anti-PD(L)1 x VEGF bispecifics!
A fascinating example of how we used multi-omics and spatial biology to create a next-generation immunotherapy!”
More posts featuring Abhishek Garg.